NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2 -Amplified Gastric Cancer von Gambardella, Valentina, Gimeno-Valiente, Francisco, Tarazona, Noelia, Martinez-Ciarpaglini, Carolina, Roda, Desamparados, Fleitas, Tania, Tolosa, Pablo, Cejalvo, Juan Miguel, Huerta, Marisol, Roselló, Susana, Castillo, Josefa, Cervantes, Andrés

Volltext

Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer von Prat, Aleix, Brasó-Maristany, Fara, Martínez-Sáez, Olga, Sanfeliu, Esther, Xia, Youli, Bellet, Meritxell, Galván, Patricia, Martínez, Débora, Pascual, Tomás, Marín-Aguilera, Mercedes, Rodríguez, Anna, Chic, Nuria, Adamo, Barbara, Paré, Laia, Vidal, Maria, Margelí, Mireia, Ballana, Ester, Gómez-Rey, Marina, Oliveira, Mafalda, Felip, Eudald, Matito, Judit, Sánchez-Bayona, Rodrigo, Suñol, Anna, Saura, Cristina, Ciruelos, Eva, Tolosa, Pablo, Muñoz, Montserrat, González-Farré, Blanca, Villagrasa, Patricia, Parker, Joel S., Perou, Charles M., Vivancos, Ana

Volltext

Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response von Brasó-Maristany, Fara, Ferrero-Cafiero, Juan Manuel, Falato, Claudette, Martínez-Sáez, Olga, Cejalvo, Juan Miguel, Margelí, Mireia, Tolosa, Pablo, Salvador-Bofill, Francisco Javier, Cruz, Josefina, González-Farré, Blanca, Sanfeliu, Esther, Òdena, Andreu, Serra, Violeta, Pardo, Francisco, Luna Barrera, Ana María, Arumi, Miriam, Guerra, Juan Antonio, Villacampa, Guillermo, Sánchez-Bayona, Rodrigo, Ciruelos, Eva, Espinosa-Bravo, Martín, Izarzugaza, Yann, Galván, Patricia, Matito, Judith, Pernas, Sonia, Vidal, Maria, Santhanagopal, Anu, Sellami, Dalila, Esker, Stephen, Fan, Pang-Dian, Suto, Fumitaka, Vivancos, Ana, Pascual, Tomás, Prat, Aleix, Oliveira, Mafalda

Volltext

The role of CDK4/6 inhibitors in early breast cancer von Gil-Gil, Miguel, Alba, Emilio, Gavilá, Joaquín, de la Haba-Rodríguez, Juan, Ciruelos, Eva, Tolosa, Pablo, Candini, Daniele, Llombart-Cussac, Antonio

Volltext

Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer von Terán, Santiago, Alva, Manuel, Tolosa, Pablo, Rey-Cárdenas, Macarena, Madariaga, Ainhoa, Lema, Laura, Ruano, Yolanda, Manso, Luis, Ciruelos, Eva, Sánchez-Bayona, Rodrigo

Volltext

Gene expression profiles of breast cancer metastasis according to organ site von Brasó‐Maristany, Fara, Paré, Laia, Chic, Nuria, Martínez‐Sáez, Olga, Pascual, Tomás, Mallafré‐Larrosa, Meritxell, Schettini, Francesco, González‐Farré, Blanca, Sanfeliu, Esther, Martínez, Débora, Galván, Patricia, Barnadas, Esther, Salinas, Belinda, Tolosa, Pablo, Ciruelos, Eva, Carcelero, Esther, Guillén, Cecilia, Adamo, Barbara, Moreno, Reinaldo, Vidal, Maria, Muñoz, Montserrat, Prat, Aleix

Volltext

Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvan... von Antolín Novoa, Silvia, Escrivá-de-Romaní, Santiago, Tolosa Ortega, Pablo, Oliva Fernández, Lucía, López López, Rafael, López González, Ana, de la Morena Barrio, Pilar, Echavarria Díaz-Guardamino, Isabel, Alés Martinez, José Enrique, Garate, Zita, González-Cortijo, Lucia

Volltext

Ribociclib-Related Stevens-Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review von López-Gómez, Victoria, Yarza, Ramón, Muñoz-González, Héctor, Revilla, Enrique, Enrech, Santos, González-Valle, Olga, Tolosa, Pablo, Ciruelos, Eva

Volltext

HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with... von Olivera-Salguero, Rubén, Seguí, Elia, Cejalvo, Juan Miguel, Oliveira, Mafalda, Tolosa, Pablo, Vidal, Maria, Malumbres, Marcos, Gavilá, Joaquín, Saura, Cristina, Pernas, Sonia, López, Rafael, Margelí, Mireia, Balmaña, Judith, Muñoz, Montserrat, Blancas, Isabel, Boni, Valentina, Ciruelos, Eva, Galve, Elena, Perelló, Antonia, Sánchez-Bayona, Rodrigo, de la Cruz, Susana, de la Hoya, Miguel, Galván, Patricia, Sanfeliu, Esther, Gonzalez-Farre, Blanca, Sirenko, Valeria, Blanch-Torras, Aura, Canes, Jordi, Masanas, Helena, Olmos, Rosa, Forns, Margarita, Prat, Aleix, Casas, Ana, Pascual, Tomás

Volltext

Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis von Villacampa, Guillermo, Tolosa, Pablo, Salvador, Fernando, Sánchez-Bayona, Rodrigo, Villanueva, Lorea, Dienstmann, Rodrigo, Ciruelos, Eva, Pascual, Tomas

Volltext

Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features von Herrera Juarez, Mercedes, Tolosa Ortega, Pablo, Sanchez de Torre, Ana, Ciruelos Gil, Eva

Volltext

Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment? von Cejalvo, Juan Miguel, Falato, Claudette, Villanueva, Lorea, Tolosa, Pablo, González, Xavier, Pascal, Mariona, Canes, Jordi, Gavilá, Joaquín, Manso, Luis, Pascual, Tomás, Prat, Aleix, Salvador, Fernando

Volltext

Efficacy and safety of weekly paclitaxel in elderly patients with heavily pretreated platinum-resistant ovarian carcinoma von Sanchez-Bayona, Rodrigo, Tolosa, Pablo, Sanchez de Torre, Ana, Castelo, Alicia, Bernal-Hertfelder, Elsa, Lema, Laura, Ciruelos, Eva M., Manso, Luis

Volltext

Abstract P5-13-24: Efficacy of first line CDK4/6 inhibitors in HER2-low vs HER2-zero, hormone receptor positive, HER2 negative metastatic breast cancer von Sanchez-Bayona, Rodrigo, Terán, Santiago, De Torre, Ana Sánchez, Alva, Manuel, Lema, Laura, Manso, Luis, Toledo, Estefanía, Roncero, Ana Maria, Merino, Cristina, Martínez, Mario, Parrilla, Lucía, Ciruelos, Eva, Tolosa, Pablo

Volltext

Abstract P1-18-34: Solti-1507 IPATHER - A phase Ib study of ipatasertib (IPAT) and dual anti-HER2 therapy with pertuzumab and trastuzumab (HP) in patients with HER2-positive (HER2+... von Oliveira, Mafalda, Ciruelos, Eva, Morales, Serafín, Gavilá, Joaquín, Quiroga, Vanesa, Vega, Estela, Bofill, Javier Salvador, Cortegoso, Alexandra, Henao, Fernando, Tolosa, Pablo, Canes, Jordi, Villagrasa, Patricia, Farré, Xavier Gonzalez, Pascual, Tomás, Saura, Cristina

Volltext

Abstract OT2-19-03: Solti-1801. Analysis of the efficacy of CDK4/6 inhibitors in combination with hormonal treatment in luminal breast cancer in relation to the intrinsic subtype a... von Tolosa, Pablo, Pascual, Tomás, Hernando, Cristina, Servitja, Sonia, Abad, María Fernández, Brasó-Maristany, Fara, Benítez, Javier, Lema, Laura, Martínez, Mario, Ruano, Yolanda, Parrilla, Lucía, Bernardini, Alejandra, Roncero, Ana María, Paré, Laia, Canes, Jordi, Villagrasa, Patricia, Salvador, Fernando, Prat, Aleix, Ciruelos, Eva

Volltext

Abstract PO-020: Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2- mBC patients during the pandemic von Tolosa, Pablo, Sanchez-Torre, Ana, de Cabo, Helena Bote, Sánchez-Bayona, Rodrigo, Herrera, Mercedes, Yarza, Ramón, Lema, Laura, Manso, Luis, Ciruelos, Eva

Volltext

Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort von Sánchez-Bayona, Rodrigo, Lopez de Sa, Alfonso, Jerez Gilarranz, Yolanda, Sanchez de Torre, Ana, Alva, Manuel, Echavarria, Isabel, Moreno, Fernando, Tolosa, Pablo, Herrero Lopez, Blanca, de Luna, Alicia, Lema, Laura, Gamez Casado, Salvador, Madariaga, Ainhoa, López-Tarruella, Sara, Manso, Luis, Bueno-Muiño, Coralia, Garcia-Saenz, Jose A., Ciruelos, Eva, Martin, Miguel

Volltext

Abstract OT-35-01: Solti-1507 A phase ib study of ipatasertib and anti-her2 therapy in her2-positive advanced breast cancer with pik3ca mutation (ipather) von Oliveira, Mafalda, Villagrasa, Patricia, Ciruelos, Eva, Gavilá, Joaquín, Cortegoso, Alexandra, Henao, Fernando, Vega, Estela, Bofill, Javier S., Quiroga, Vanesa, García-Estevez, Laura, Morales, Serafín, Tolosa, Pablo, Céliz, Pamela, Farré, Xavier Gonzalez, Saura, Cristina

Volltext

Abstract PD8-03: Palbociclib and trastuzumab for HER2-positive metastatic breast cancer (SOLTI-1303 PATRICIA): Final results from cohort A and B, prospective, open-label, multicent... von Ciruelos, Eva, Pascual, Tomás, Oliveira, Mafalda, Escrivá-de-Romaní, Santiago, Pernas, Sonia, Paré, Laia, Adamo, Barbara, Martínez, Eduardo, Cortés, Javier, Perelló, Antonia, Galan, Maria, Melé, Mireia, Tolosa, Pablo, González-Farré, Blanca, Galván, Patricia, Canes, Jordi, Nuciforo, Paolo, Gonzalez, Xavier, Villagrasa, Patricia, Prat, Aleix

Volltext